Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales

The monthly maintenance regimen, which offers a more convenient frequency than the initially approved treatment schedule for patients with Alzheimer’s, could help with Leqembi’s thus far disappointing uptake and sales.